Does PRALSETINIB Cause Blood creatine phosphokinase increased? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Blood creatine phosphokinase increased have been filed in association with PRALSETINIB (Gavreto). This represents 1.4% of all adverse event reports for PRALSETINIB.
20
Reports of Blood creatine phosphokinase increased with PRALSETINIB
1.4%
of all PRALSETINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Blood creatine phosphokinase increased From PRALSETINIB?
Of the 20 reports, 10 (50.0%) required hospitalization.
Is Blood creatine phosphokinase increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PRALSETINIB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does PRALSETINIB Cause?
Death (126)
Fatigue (104)
Asthenia (96)
Off label use (92)
Hypertension (89)
Disease progression (85)
Anaemia (80)
Diarrhoea (79)
Pyrexia (75)
White blood cell count decreased (74)
What Other Drugs Cause Blood creatine phosphokinase increased?
ATORVASTATIN (1,491)
SIMVASTATIN (895)
ROSUVASTATIN (859)
QUETIAPINE (663)
CLOZAPINE (610)
ARIPIPRAZOLE (594)
OLANZAPINE (561)
DAPTOMYCIN (461)
RISPERIDONE (402)
EZETIMIBE (350)
Which PRALSETINIB Alternatives Have Lower Blood creatine phosphokinase increased Risk?
PRALSETINIB vs PRAMIPEXOLE
PRALSETINIB vs PRAMIPEXOLE\PRAMIPEXOLE
PRALSETINIB vs PRAMLINTIDE
PRALSETINIB vs PRASTERONE
PRALSETINIB vs PRASUGREL